Blockchain in Genomics Market Size, Share, By Component (Software and Platforms), Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), Deployment Model (On-premise and Cloud-based), Application (Secure Data Sharing, Patient Consent Management, Data Provenance and Integrity, Genomic Data Repositories, Enhanced Data Analytics, and Others), End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Hospitals and Clinics, Government Agencies, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Nebula Genomics, Inc.
• GenoBank.io
• Lifebit Biotech Ltd
• Stellarix.com
• QIAGEN
• Zenome
• Oasis Labs
• DNAtix
• EncrypGen
• GenomicDAO

Recent News:

• GenomesDAO, a pioneering biotech company focused on the secure, private, and auditable monetization of genomic data, announced the successful completion of a new collaboration with Pantera Capital and Modular Capital, whose expertise in scaling blockchain companies was invaluable, thereby helping in advancing the genomics market with the help of blockchain technology, in June 2024.
• Nebula Genomics integrated with Oasis Labs to give users first-of-its-kind control of its personal genomic data with the help of blockchain technology, in September 2020. From massive data breaches to sales of private data, users and companies were more concerned than ever with keeping personal health information private and secure.